Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


European Regulatory Round Up: While EMA Opens Up, European Pharma Battens Down For Tough Year

Executive Summary

The European Medicines Agency is focusing on transparency and pharmacovigilance over the next year, while the pharmaceutical industry is gearing up for a fight against austerity measures.


Related Content

EMA Revamp Could Be Hampered By Tight Budget And Staffing
EMA’s Heralded Revamp May Be Hampered By Tight Budget And Staffing
Korea’s Shin Poong Pharmaceutical Cuts Biotech Deal With France’s LFB Biotechnologies
Rasi At The EMA: Redefining Benefit/Risk As Staggered Approvals Rise
European Regulatory Round-Up: EMA And The UK Heed The Calls Of Industry; France Is Otherwise Occupied
Germany To Disclose Rx Pricing Discounts, Setting A Potential Benchmark For Europe
The Year Ahead In Europe: More Price Cuts, More Austerity
EMA's First PUMA Recommendation Is One Small Step For Kids


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts